SIBN

23.7300.08%
TE

Timothy E. Davis

Lead Independent Director

Mr. Timothy E. Davis, Jr. also known as Ted Jr. is President & Chief Executive Officer of Bio-Tissue, Inc. and serves as its Director since September 2026. Mr. Davis is Non-Executive Director of Axis Spine Technologies Ltd. Mr. Davis has served as President and Chief Executive Officer of Active Implants, LLC, a company that provides orthopedic implant solutions, since February 2017. He serves as an Independent Director of SI-BONE, Inc. since April 2008 and has been its Lead Independent Director since December 2021. He has been President and Chief Executive Officer TissueTech, Inc. since January 03, 2022. He served as Lead Independent Director of SI-BONE, Inc. from 2019 until April 2021. He joined the SI-BONE, Inc. in April 2008. From January 2014 through September 2015, Mr. Davis served as Chief Executive Officer of MicroPort Orthopedics, Inc., a multinational producer of orthopedic products, following the purchase of Wright Medical Group’s OrthoRecon Business in January 2014. From December 2006 to January 2014, Mr. Davis served in a number of executive positions for Wright Medical Technology, Inc. He was a Partner at MB Venture Partners from 2004 to 2006. Mr. Davis served as the President of Orthorecon Division at Wright Medical Group Inc. since November 2012 and as its Senior Vice President of Corporate Development since January 2010, Interim Head of Research & Development since May 2011, Vice President of Business Development since 2006 and Vice President of Corporate Development from December 2006 to January 2010. He served as Vice President of Vector Securities International, LLC. From 1997 to 2004, he served as the Vice President of Vector Fund Management, L.P. (VFM). While at VFM, he focused on investment opportunities in the biotechnology, medical device and healthcare information technology industries. Prior to joining Vector in 1997, he had experience in the healthcare management consulting and pharmaceutical industries. He was a Senior Consultant at Gemini Consulting Group, Inc., where he focused on the strategic integration of healthcare providers in the creation of integrated delivery systems. Before joining Gemini, he was a Sales Specialist with Parke-Davis Co., where he promoted cardiovascular and neurological therapies to community and hospital based physicians. At Kellogg, he co-founded the Business of Healthcare Conference, which contributed to the school’s creation of a life sciences initiative. He serves on the Board of Alveolus, Inc. He serves as a Board Member of the Kellogg Center for Biotechnology. He serves as a Board Observer at KFx Medical Corporation. He served as a Board Member or Observer for VFM at ACIST Medical, Acorda Therapeutics, Axya Medical, Cellular Genomics, Optical Dynamics Corporation and SciQuest. He served on the Board of the Illinois Biotechnology Industry organization. Mr. Davis holds a B.E. in Biomedical Engineering from Vanderbilt University and his M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University, where he was a Rothschild Scholar and Marion Wade Scholar.

公司職務